Felodipine transdermal device and methods

US7018649B2 · kind B2 · utility

Assignee

• Euro-Celtique S.A. · LU

Inventors

• Lino Tavares · Kinnelon, US
• Ihor Shevchuk · Yonkers, US
• Mark Alfonso · Easton, US
• Geraldine Marcenyac · Norwalk, US
• Kirti H. Valia · Plainsboro, US

Key dates

• Filing date: Oct 23, 2001
• Grant date: Mar 28, 2006
• Expiry date: Oct 23, 2021

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61K31/4422
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

A method of effectively treating hypertension in humans is achieved by administering felodipine via a transdermal formulation. Preferably, the transdermal formulation is applied to the skin of the patient and maintained in contact with the skin for at least about 24 hours days, and preferably for about 3 to about 8 days.